Thrombocytopenic Purpura

Thrombocytopenic Purpura

Thrombocytopenic Purpura (often called Immune Thrombocytopenic Purpura or ITP) is a rare blood disorder that can, in some cases, develop after vaccination.

It happens when the body’s immune system mistakenly targets and destroys its own platelets, the tiny cells that help blood clot.

When platelet levels drop too low, the blood cannot clot properly, leading to easy bruising, bleeding, and sometimes serious internal bleeding. In most cases, symptoms appear within days or weeks after vaccination, though timing can vary.

Common signs and symptoms of ITP include:

  • Unusual bruising that appears suddenly or in unexpected areas

  • Tiny purple or red spots on the skin (known as petechiae)

  • Prolonged bleeding from cuts, gums, or nosebleeds

  • Heavy or irregular menstrual bleeding in women

  • Fatigue or dizziness due to blood loss

  • Blood in urine or stool (less common, but serious)

While most people recover fully with proper medical treatment, ITP can cause significant distress and, in severe cases, require hospitalization, transfusions, or long-term therapy.

If you or your child developed unexplained bruising, bleeding, or low platelet counts after a vaccination, you may be eligible to file a claim through the Vaccine Injury Compensation Program (VICP).

This program provides financial compensation for medical expenses, lost wages, and pain and suffering for qualifying vaccine-related injuries.

There are strict filing deadlines — typically within three years of symptom onset — so if you think you may have a claim, contact Pearsall Law now to begin the process and preserve your right to compensation.

  • Immune Thrombocytopenic Purpura (ITP) is a rare autoimmune blood disorder in which the body’s immune system mistakenly attacks and destroys its own platelets, which are the blood cells that help control bleeding.

    Without enough platelets, even small injuries can lead to excessive bruising or bleeding.

    There are two types of ITP:

    • Acute ITP, which often occurs suddenly and may resolve on its own (more common in children).

    • Chronic ITP, which can last for months or years (more common in adults).

    ITP is not contagious, and it is distinct from other blood disorders because platelet counts can fluctuate dramatically over time. It may follow certain viral infections, medications, or vaccination.

  • A small number of people can experience an abnormal immune response after vaccination that mistakenly targets platelets. This can trigger ITP.

    The Vaccine Injury Compensation Program (VICP) recognizes ITP as a potential adverse event following vaccination.

    This means people who develop ITP within a reasonable timeframe after receiving a covered vaccine may qualify for compensation.

    The immune system’s overreaction can cause:

    • Platelet destruction in the spleen

    • Autoantibodies that mark platelets for removal

    • Low platelet counts, leading to bruising and bleeding

    These reactions are rare, but they can have serious physical and financial consequences. That is why we fight so hard to maximize your compensation under the VICP.

  • ITP symptoms can range from mild to severe. Many people first notice easy bruising or bleeding that seems out of proportion to any injury.

    Children may develop small red or purple dots on their skin, while adults might experience nosebleeds or fatigue.

    Common symptoms include:

    • Unexplained bruises or purple spots (petechiae)

    • Prolonged bleeding from minor cuts or dental work

    • Nosebleeds or bleeding gums

    • Heavy menstrual periods

    • Fatigue or weakness

    Severe cases can involve internal bleeding, which is a medical emergency. Anyone with very low platelet counts or sudden severe symptoms should seek medical care immediately.

  • Treatment depends on the severity of the condition and platelet count.

    Some mild cases resolve on their own, while others require medical intervention to stop immune destruction and boost platelet levels.

    Typical treatments include:

    • Corticosteroids (like prednisone) to suppress immune activity

    • IV immunoglobulin (IVIG) to protect platelets from destruction

    • Platelet transfusions in emergency bleeding situations

    • Splenectomy (removal of the spleen) in chronic cases

    • Newer medications that stimulate platelet production

    With proper treatment, most patients recover fully or manage the condition successfully long term.

    • ITP is considered rare, but it affects thousands of Americans each year.

      Key statistics:

      • About 3 to 4 new cases per 100,000 adults occur annually.

      • In children, it’s most common between ages 2 and 5, often after a viral illness or vaccination.

      • Approximately 70% of childhood ITP cases resolve within six months.

      • Chronic ITP affects roughly 60,000 adults in the U.S. at any given time.

      • Vaccine-related ITP is extremely rare — estimated at 1 in 40,000 to 1 in 100,000 vaccine doses for MMR.

      Even though ITP is rare, its impact can be serious and long-lasting. If ITP develops after vaccination, it’s important to act quickly to preserve your right to compensation under the VICP, before the deadline to file a claim.

Two test tubes filled with dark red liquid, one with a purple cap and the other with a red cap, placed on a light green background.